Victoria W D’Agostino

Ms. Victoria W D’Agostino

Duke University, Durham, California, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
DPDivya Pathania
Divya Pathania
CLChristian Landeros
Christian Landeros
LRLucas Rohrer
Lucas Rohrer
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
SHSeonki Hong
Seonki Hong
CCCesar M. Castro
Cesar M. Castro
Most deaths (80%) from cervical cancer occur in regions lacking adequate screening infrastructures or ready access to them. In contrast, most developed countries now embrace human papillomavirus (HPV) analyses as standalone screening; this transition threatens to further widen the resource gap.

5 April 2024 in Science Advances
Verified
Journal Article
Open access
ESEnakshi D. Sunassee
Enakshi D. Sunassee
RDRiley Joseph Deutsch
Riley Joseph Deutsch
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
PCPol Castellano-Escuder
Pol Castellano-Escuder
ESElizabeth A. Siebeneck
Elizabeth A. Siebeneck
NRNirmala Ramanujam
Nirmala Ramanujam
Fewer than 20% of triple-negative breast cancer patients experience long-term responses to mainstay chemotherapy. Resistant tumor subpopulations use alternative metabolic pathways to escape therapy, survive, and eventually recur. Here, we show in vivo, longitudinal metabolic reprogramming in residual disease and recurrence of triple-negative breast cancer xenografts with varying sensitivities to the chemotherapeutic drug paclitaxel. Optical imaging coupled with metabolomics reported an increase in non–glucose–driven mitochondrial metabolism and an increase in intratumoral metabolic heterogeneity during regression and residual disease in resistant MDA-MB-231 tumors. Conversely, sensitive HCC-1806 tumors were primarily reliant on glucose uptake and minimal changes in metabolism or heterogeneity were observed over the tumors’ therapeutic life cycles. Further, day-matched resistant HCC-1806 tumors revealed a higher reliance on mitochondrial metabolism and elevated metabolic heterogeneity compared to sensitive HCC-1806 tumors. Together, metabolic flexibility, increased reliance on mitochondrial metabolism, and increased metabolic heterogeneity are defining characteristics of persistent residual disease, features that will inform the appropriate type and timing of therapies.

19 April 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
RDRiley Joseph Deutsch
Riley Joseph Deutsch
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
ESEnakshi D. Sunassee
Enakshi D. Sunassee
MKMichelle Kwan
Michelle Kwan
MMMegan Madonna
Megan Madonna
NRNimmi Ramanujam
Nimmi Ramanujam
Aggressive breast cancer has been shown to shift its metabolism towards increased lipid catabolism as the primary carbon source for oxidative phosphorylation. In this study, we present a technique to longitudinally monitor lipid metabolism and oxidative phosphorylation in pre-clinical tumor models to investigate the metabolic changes with mammary tissue development and characterize metabolic differences between primary murine breast cancer and normal mammary tissue. We used optical spectroscopy to measure the signal of two simultaneously injected exogenous fluorescent metabolic reporters: TMRE (oxidative phosphorylation surrogate) and Bodipy FL C16 (lipid catabolism surrogate). We leverage an inverse Monte Carlo algorithm to correct for aberrations resulting from tissue optical properties and to extract vascular endpoints relevant to oxidative metabolism, specifically oxygen saturation (SO2) and hemoglobin concentration ([Hb]). We extensively validated our optical method to demonstrate that our two fluorescent metabolic endpoints can be measured without chemical or optical crosstalk and that dual measurements of both fluorophores in vivo faithfully recapitulate the measurements of each fluorophore independently. We then applied our method to track the metabolism of growing 4T1 and 67NR breast tumors and aging mammary tissue, all highly metabolic tissue types. Our results show the changes in metabolism as a function of mammary age and tumor growth, and these changes can be best distinguished through the combination of endpoints measured with our system. Clustering analysis incorporating both Bodipy FL C16 and TMRE endpoints combined with either SO2 or [Hb] proved to be the most effective in minimizing intra-group variance and maximizing inter-group differences. Our platform can be extended to applications in which long-term metabolic flexibility is important to study, for example in tumor regression, recurrence following dormancy, and responses to cancer treatment.

1 July 2024 in Biophotonics Discovery
Verified
Journal Article
Open access
PDF file
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
RDRiley J. Deutsch
Riley J. Deutsch
MKMichelle Kwan
Michelle Kwan
ESEnakshi D. Sunassee
Enakshi D. Sunassee
MMMegan Madonna
Megan Madonna
NRNirmala Ramanujam
Nirmala Ramanujam
SignificanceEmerging evidence that aggressive breast tumors rely on various substrates including lipids and glucose to proliferate and recur necessitates the development of tools to track multiple metabolic and vascular endpoints concurrently in vivo.AimOur quantitative spectroscopy technique provides time-matched measurements of the three major axes of breast cancer metabolism as well as tissue vascular properties in vivo.ApproachWe leverage exogenous fluorophores to quantify oxidative phosphorylation, glucose uptake, and fatty acid oxidation, and endogenous contrast for measurements of hemoglobin and oxygen saturation. An inverse Monte Carlo algorithm corrects for aberrations resulting from tissue optical properties, allowing the unmixing of spectrally overlapping fluorophores.ResultsImplementation of our inverse Monte Carlo resulted in a linear relationship of fluorophore intensity with concentration (R2<0.99) in tissue-mimicking phantom validation studies. We next sequenced fluorophore delivery to faithfully recapitulate independent measurement of each fluorophore. The ratio of Bodipy FL C16/2-NBDG administered to a single animal is not different from that in paired animals receiving individual fluorophores (p=n.s.). Clustering of five variables was effective in distinguishing tumor from mammary tissue (sensitivity = 0.75, specificity = 0.83, and accuracy = 0.79).ConclusionsOur system can measure major axes of metabolism and associated vascular endpoints, allowing for future study of tumor metabolic flexibility.

1 January 2024
Verified
Conference Paper
Closed access
PDF file
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
MKMichelle Kwan
Michelle Kwan
MMMegan C. Madonna
Megan C. Madonna
BCBrian T. Crouch
Brian T. Crouch
NRNirmala Ramanujam
Nirmala Ramanujam
We have developed and validated an in vivo quantitative spectroscopy method to measure spectrally overlapping fluorophores relevant to cancer metabolism using an inverse Monte Carlo algorithm and linear spectral unmixing.

10 February 2026 in PNAS Nexus
Verified
Journal Article
Open access
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
MKMichelle Kwan
Michelle Kwan
AYAdelle Yong
Adelle Yong
KGKira Grossman
Kira Grossman
ESEnakshi D Sunassee
Enakshi D Sunassee
NRNirmala Ramanujam
Nirmala Ramanujam
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis and a high likelihood of recurrence. Residual disease after therapy is a key predictor of recurrence, often driven by intratumoral metabolic heterogeneity. Accumulating evidence indicates that tumors are able to shift between glycolysis and oxidative metabolism and alter nutrient preferences to sustain growth and resist therapy. We have developed a in vivo microscope that enables near-simultaneous measurements of fluorescent metabolic surrogates of glucose, fatty acids, and oxidative phosphorylation through a combination of spectral separation and sequential delivery schemes. Widefield imaging with uniform illumination across the entire tumor landscape (5 mm × 5 mm) informs on the spatial distribution of these metabolic probes. We used this technology to investigate metabolic heterogeneity of a murine model of TNBC (4T1 tumor line) and normal mammary tissues that have distinctly different metabolic pathways. Mammary tissues relied primarily on oxidative metabolism and showed high levels of glucose and fatty acid uptake across the entire imaging area reflecting a single metabolic phenotype. Though tumors were predominantly glycolytic, they displayed a heterogeneous distribution of nutrient preferences with regions dominated by either fatty acid uptake, glucose uptake, or both. Taken together, this work highlights the importance of not only capturing multiple metabolic endpoints but also investigating their spatial relationships to understand heterogeneity in key substrates and metabolic pathways for energy production in vivo.